MedTrace Logo

In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides

NCT02159937 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2015-08-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate in vitro the potential of peptides, to modify, phenotypically and functionally, the monocyte-derived dendritic cells of patients with metastatic cancer.

Conditions

Interventions

OTHER

Blood sampling by vena punction.

In vitro tests will be performed after blood sample collection from metastatic cancer patients

Sponsors & Collaborators

  • Recepta Biopharma

    lead INDUSTRY

Principal Investigators

  • José AM Barbuto, Ph.D · Departamento de Imunologia - Instituto de Ciências Biomédicas da Universidade de São Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02159937 on ClinicalTrials.gov